Indoleamine 2,3-dioxygenase-regulated macrophages metabolic reprogramming rescues tacrolimus-induced nephrotoxicity
Frontiers in Pharmacology · 18.03.2026 · 17
DOI: 10.3389/fphar.2026.1784153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.03.2026. Verfasst von Menghan Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Macrophage metabolic reprogramming toward the M1 phenotype is a key pathological feature of kidney injury. Recent studies have increasingly highlighted the importance of de novo NAD + synthesis in the development of renal damage. In this study, we found that tacrolimus (TAC) suppressed the activity of indoleamine-2,3-dioxygenase 1 (IDO1), thereby blocking the conversion of tryptophan (Trp) to kynurenine (KYN), impairing de novo NAD + synthesis. NAD + deficiency enhances glycolysis, causes accumulation of medium-to long-chain fatty acids and acylcarnitines, indicating impaired fatty acid β-oxidation, thereby promoting M1 polarization and exacerbating renal injury. Further investigations revealed that restoring NAD + levels via exogenous KYN supplementation or directly activating peroxisome proliferator-activated receptor alpha (PPARα) to enhance fatty acid oxidation effectively reversed this metabolic imbalance and alleviated TAC-induced kidney injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, M., Zhang, R., Guo, P., Zhou, J., Yu, D., Shang, T., Li, P., Li, J., Liu, K., Liu, Y., & Shi, S. (2026). Indoleamine 2,3-dioxygenase-regulated macrophages metabolic reprogramming rescues tacrolimus-induced nephrotoxicity. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1784153
Vancouver
Ye M, Zhang R, Guo P, Zhou J, Yu D, Shang T, et al. Indoleamine 2,3-dioxygenase-regulated macrophages metabolic reprogramming rescues tacrolimus-induced nephrotoxicity. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1784153
BibTeX
@article{Ye2026,
author = {Ye, Menghan and Zhang, Rui and Guo, Pengpeng and Zhou, Jinping and Yu, Dianwen and Shang, Tianze and Li, Peixia and Li, Jiaxin and Liu, Kaiyu and Liu, Yani and Shi, Shaojun},
title = {Indoleamine 2,3-dioxygenase-regulated macrophages metabolic reprogramming rescues tacrolimus-induced nephrotoxicity},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1784153}
}
EUVIMED